when to stop taking glp 1 Researchers find GLP-1 medications safe continue before surgery in patients with diabetes and obesity Ever wonder what happens when

GLP-1 weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, researchers wrote in a new study.

Results The PS-matched cohorts (n=784 each) had similar baseline characteristics

No artificial sweeteners

Patient intake packet (demographics, goals, weight loss history, medication/supplement list, lifestyle readiness)

Double your GLP-1 in just one use!

The patient must: Be age 18 or older Have eligible Medicare Part D coverage Be prescribed treatment specifically for weight reduction and maintenance Participate in ongoing nutrition and physical activity intervention Not have already received a GLP-1 through their Part D plan Not be seeking coverage for another Part D-coverable indication, such as type 2 diabetes, moderate-to-severe obstructive sleep apnea, MASH, or cardiovascular risk reduction The patient must also have met one of these criteria when GLP-1 therapy was originally started: BMI 35 BMI 30 plus HFpEF, uncontrolled hypertension despite 2 medications, or CKD stage 3a+ BMI 27 plus prediabetes, prior MI, prior stroke, or symptomatic peripheral artery disease Important: Eligibility is based on BMI at treatment initiation, not necessarily the patients current BMI